1.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
by Powles, Thomas
The lancet oncology, 2021-07, Vol.22 (7), p.931-945
2.
Biotech leaders call for free press
by Cohen, Ron
Nature biotechnology, 2018-10-11, Vol.36 (10), p.920-922
Filter electronic articles 2 Hits
Remove Filters
- Subjects
- Cancer
- Life Sciences & Biomedicine (2)
- Science & Technology (2)
- more ...